Johnson & Johnson (JNJ) Tops Q3 EPS by 4c; Boosts FY15 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Wall St. declines on China fears, weak profit expectations
October 13, 2015 7:20 AM EDTBy Caroline Valetkevitch
(Reuters) - U.S. stocks fell on Tuesday, with the Dow snapping a seven-day winning streak, on renewed fears of slowing growth in China and another bout of selling in biotech shares.
Biotechs led the S&P 500 and Nasdaq lower and the S&P health care index , down 1.2 percent, had the biggest losses among S&P sectors, followed by industrials , down 1.1 percent. The Nasdaq Biotech Index was down 3.2 percent, extending recent declines.
Worries about third-quarter earnings reports continued to weigh on sentiment. Earnings for S&P 500 companies are expected... More
Johnson & Johnson plans to buy back shares up to $10 billion
October 13, 2015 7:07 AM EDT(Reuters) - Drugmaker Johnson & Johnson (NYSE: JNJ) said it plans to buy back up to $10 billion of common stock over time.
The company said on Tuesday it had about 2.77 billion shares of common stock outstanding as of Sept. 27, valuing the company at $251.82 billion
... More